Last reviewed · How we verify
NCT06269237
Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment
NA trial testing M22 in Dry Eye in 30 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | He Eye Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 22 February 2024 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 July 2024 |
Drugs / interventions tested
- M22
- sham M22
Conditions studied
- Dry Eye — all drugs for Dry Eye →
Sponsor
He Eye Hospital
Who can join
Adults 18 to 90, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To quantify and compare tear levels of Intense pulsed light (IPL) and traditional dry eye clinical tests in dry eye patients before and after Intense pulsed light (IPL) treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intense pulsed light treatment improved tear film quality and reduced ocular surface inflammation in dry eye patients.
Chen J, Zhang Y, Yu S, Zhang Q, et al · · 2025 · PMID 41423659 · DOI 10.1038/s41598-025-29319-1
Verify or expand the search:
- PubMed search for NCT06269237
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dry Eye
Currently open trials in the same condition.
- NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
- NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
- NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
- NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
- NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting
Other He Eye Hospital trials
Trials by the same sponsor.
- NCT07097922 — Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients With Dry Eye After LASIK · NA · not yet recruiting
- NCT06852105 — Compare the Clinical Efficacy of 3% Diquafosol and 0.1% Hyaluronic Acid in Patients with Dry Eye After Trans-PRK · NA · not yet recruiting
- NCT06714994 — Effect of Spectacle Distribution to Myopic Secondary School Students in Rural Communities of Liaoning Province on Commun · NA · not yet recruiting
- NCT06656403 — Effect of Artificial Tears on Ocular Biometry Parameters · NA · not yet recruiting
- NCT06537349 — Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06269237 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by He Eye Hospital
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06269237.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing